| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 16.757 | 37.322 | 30.955 | 14.651 | 8.441 | 18.380 | 23.174 | 26.727 | 25.622 |
| Total Income - EUR | - | 16.757 | 37.322 | 30.955 | 14.651 | 8.441 | 18.380 | 25.137 | 26.727 | 25.793 |
| Total Expenses - EUR | - | 2.105 | 6.163 | 41.866 | 2.970 | 4.241 | 4.869 | 5.859 | 10.205 | 10.465 |
| Gross Profit/Loss - EUR | - | 14.653 | 31.158 | -10.911 | 11.681 | 4.200 | 13.511 | 19.278 | 16.522 | 15.327 |
| Net Profit/Loss - EUR | - | 14.150 | 30.039 | -11.840 | 11.241 | 3.964 | 12.959 | 18.597 | 16.260 | 15.073 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gevmed Urologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 27.434 | 234 | 721 | 1.107 | 292 | 2.122 | 2.116 | 2.104 |
| Current Assets | - | 14.363 | 21.397 | 22.280 | 27.256 | 25.091 | 32.640 | 17.209 | 17.983 | 15.633 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.643 | 2.748 | 3.079 | 0 | 174 | 166 | 16.131 | 14.124 | 503 |
| Cash | - | 12.720 | 18.648 | 19.201 | 27.256 | 24.917 | 32.474 | 1.077 | 3.859 | 15.130 |
| Shareholders Funds | - | 14.195 | 34.798 | 22.319 | 27.881 | 25.796 | 32.624 | 18.645 | 16.309 | 15.122 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 168 | 14.033 | 194 | 96 | 403 | 307 | 686 | 3.791 | 2.615 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gevmed Urologie S.r.l.